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Objective: Claudication is the most common manifestation of peripheral arterial disease (PAD), producing significant
ambulatory compromise. The gait of claudicating patients has been evaluated using primarily temporal and spatial
parameters. With the present study, we used advanced biomechanical measures to further delineate the ambulatory
impairment of claudicating patients. We hypothesized that the claudicating legs of PAD patients have an altered kinetic
gait pattern compared with normal legs from control subjects.
Methods: Ambulation kinetics (ground reaction forces) were evaluated in claudicating patients and compared with
age-matched healthy controls. Forces were analyzed in the vertical, anterior–posterior, and medial–lateral directions.
Time from heel touch-down to toe-off (stance time) and time spent in double-limb support were also evaluated.
Results: The study recruited 14 PAD patients (age, 58  3.4 years; weight, 80.99  15.64 kg) with femoropopliteal
occlusive disease (ankle-brachial index [ABI], 0.56 0.03) and five controls (age, 53 3.4 years; weight, 87.38 12.75
kg; ABI, >1.00). Vertical force curve evaluation demonstrated significant flattening in claudicating patients resulting in
a lower and less fluctuant center of mass when ambulating. In the anterior–posterior direction, claudicating patients
demonstrated significantly decreased propulsion forces. In the medial–lateral direction, they had significantly increased
forces consistent with wider steps and an inability to swing their legs straight through. Claudicating patients demon-
strated a greater stance time and time in double limb support compared with healthy controls. Most importantly, gait
abnormalities were present before the onset of claudication, with gait worsening after the onset of claudication.
Conclusion: Claudicating patients demonstrate significant gait impairments that are present even before they experience
any limb discomfort. These alterations may make them feel more stable and secure while attempting to minimize use of
the affected limb. Advanced biomechanical analysis, using ambulation kinetics, permits objective and quantitative
evaluation of the gaits of claudicating patients. Such evaluation may point to new rehabilitation strategies and provide
objective measurement of functional outcomes after medical and surgical therapy. (J Vasc Surg 2007;46:491-9.)Peripheral arterial disease (PAD) is the result of lower
limb arterial atherosclerosis and affects more than 8.4 mil-
lion people in the United States.1,2 The most common
presentation of PAD is intermittent claudication. Patients
with claudication are unable to ambulate normally due to
tightness, pain, and fatigue produced by decreased circula-
tion to the exercising leg muscles. In healthy individuals,
exercise induces a marked increase in skeletal muscle me-
tabolism that results in a 20-fold to 40-fold increase in
skeletal muscle blood flow and oxygen delivery.3 In patients
with claudication, a deficient oxygen supply compared with
the demand causes the exercising muscle to become pro-
gressively more ischemic and painful. Thus, the patient
walks initially without pain, subsequently limps (claudica-
tion), and is eventually forced to stop walking.
The evaluation of gait in PAD patients has been largely
limited to time and distancemeasurements such as stride, step
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doi:10.1016/j.jvs.2007.05.029length, stance time, speed, and cadence obtained by inspec-
tion, and timing of patients’ walking performances.4-7 These
initial studies found PAD patients walk slower5-8 and have a
shortened step length5,8 and a reduced cadence.5,7,8 Fur-
thermore, patients appear to have impaired balance, as
indicated by a shorter unipedal stance time, a higher prev-
alence of ambulatory stumbling, and an increased preva-
lence of falling compared with healthy controls.8,9
A limited attempt at a more detailed analysis of claudicat-
ing limb gait was also attempted with the use of pressure-
sensing insoles during treadmill walking. The work demon-
strated progressively decreasing pressure values as claudicating
patients walk.10 The studies to date document significant
ambulation abnormalities in claudicating patients, but give
little insight into the exact biomechanical mechanisms pro-
ducing the abnormal findings.
To fully understand the ambulation abnormalities in
claudicating patients, our group has pursued advanced
biomechanical evaluations of people with and without
claudication. The biomechanical measures include an
evaluation of lower extremity kinetics. This measures the
forces exerted by the subject’s weight-bearing limb on
the ground, also known as ground reaction forces, a
direct application of Newton’s third law of motion con-
cerning action-reaction.11 The ambulating individual
pushes the ground with a force, and the ground exerts an
equal and opposite force. For clinical analysis, this force is
resolved into three components orthogonal to each other
491
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three-dimensional system (Fig 1). The magnitude and di-
rection of these forces can be collected using a standard
piezoelectric force plate.
Although a common practice in many other clinical
domains, no studies, to our knowledge, have examined
claudicating patients with advanced biomechanical analy-
sis.12-14 Biomechanical analysis has quantified the efficacy
of surgical procedures to improve gait in children with
cerebral palsy, including guiding postoperative rehabilita-
tion strategies.15-17 Joint replacement operations have
been evaluated extensively for biomechanical properties,
longevity, and patient satisfaction.18,19 In patients with
anterior cruciate ligament deficiency, advanced biome-
chanical evaluations identified specific gait alterations cur-
rently being addressed through precise rehabilitationmeth-
odologies to restore normal gait.20,21 Furthermore,
rehabilitation strategies for patients with stroke and ampu-
tation have undergone thorough biomechanical analysis to
identify objective gains in mobility.22-24 In contrast to the
progress made in these fields, Gardner and Montgomery9
correctly state that very little has been done to understand
the underlying biomechanical gait abnormalities produced
by PAD.9
This investigation used advanced kinetic biomechanical
testing to evaluate and characterize the ambulatory pattern
of PAD patients. We hypothesized that the claudicating
legs of PAD patients have an altered kinetic gait pattern
compared with normal legs from control subjects. This
study provides initial data on the gait abnormalities of
claudicating patients that can be used as the necessary
foundation for the development of new rehabilitation strat-
egies and the initiation of studies that may optimally quan-
tify the effects of drugs and revascularization for patients
Fig 1. Lower extremity kinetic evaluation measures the forces
exerted by the subject’s weight-bearing limb on the ground, also
known as ground reaction forces. The magnitude and direction of
these forces can be collected using a standard piezoelectric force
plate embedded in the ground. For clinical analysis, these forces are
resolved into three components orthogonal to each other (vertical
or Fz, anterior–posterior or Fy, and medial–lateral or Fx) along a
three-dimensional system.with PAD.METHODS
Subjects. Appropriate Institutional Review Board ap-
proval was obtained before the study was initiated, and all
subjects provided informed consent. Patients with clinically
diagnosed femoropopliteal PAD presenting with unilateral
or bilateral calf claudication were recruited from our vascu-
lar surgery clinic. Patients were free of any confounding
variables that could limit or alter their gait, including
significant cardiac, pulmonary, neurologic, diabetic, or
musculoskeletal disease. Specifically, subjects were ex-
cluded if they had recent myocardial infarction or unsta-
ble angina and ambulation-limiting heart failure, angina,
or pulmonary disease. Subjects were also excluded if they
had ambulation-limiting neurologic or musculoskeletal
disease such as paresis, sciatica, diabetic neuropathy, or
arthropathy.
Subjects were evaluated by history and physical exami-
nation, and femoropopliteal disease was verified by nonin-
vasive testing and by computed tomography scanning,
magnetic resonance imaging, or invasive angiography.
These assessments were used to establish limbs with occlu-
sive disease and typical symptoms as “claudicating limbs”
and select them for biomechanical analysis.
Control subjects were recruited from the community,
with a detailed history, physical examination, and noninva-
sive testing performed to establish absence of PAD, claudi-
cation, and confounding variables. Controls were selected
to have similar age, body mass index (BMI), and physical
activity level with the PAD subjects. Each leg of these
individuals was used as “control limb.” Height and weight
were measured for all participants and BMI was calculated.
To eliminate variability in gait due to shoes, all subjects
wore the same standard laboratory shoes (Cross Trekkers,
Payless Shoes, Topeka, Kan).
Lower extremity kinetics. The magnitude and direc-
tion of the ground reaction forces were collected using a
standard piezoelectric force plate (Kistler Force Platform,
Amherst, NY) with a sampling frequency of 600 Hz.11 As
already mentioned, ground reaction forces are those ex-
erted by the subject’s weight-bearing limb on the ground
and are a direct application of Newton’s third law ofmotion
concerning action-reaction.11 The ambulating individual
pushes the ground with a force and the ground exerts an
equal and opposite force. For clinical analysis, this force is
resolved into three components orthogonal to each other
along a three-dimensional system (Fig 2). The compo-
nents are labeled: Fz, vertical (up–down) component; Fy,
anterior–posterior (forward–backward) component; and
Fx , medial–lateral (side–side) component).
11
The patients walked on the force plate, with each leg
undergoing five trials (10 trials per person). Because of
claudication, ambulation was limited to three strides before
and after striking the force plate, thus eliminating the
possibility of pain in the affected limbs. All patients were
required to rest in a chair for several minutes before and
between trials to ensure “before onset of claudication”
measurements were pain free. Kinetic data were collected
zero
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senting one entire stance cycle. Determination of first leg to
be collected was randomized.
Once PAD patients completed “before onset of claudi-
cation” pain-free trials, they ambulated until claudication
Fig 2. Typical force plate data from a control subject
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second gait test. Healthy controls followed a similar proto-
col. Because they experience no claudication symptoms, no
“after onset of claudication” data were collected.
Data analysis. The force platform was interfaced with
the Peak Motus system (Peak Performance Technologies,
Englewood, Colo). Raw analog force data were then ex-
tracted, and the data files were further analyzed by using
custom software created with Matlab (Mathworks Inc,
Natick, Mass). The medial–lateral (Fx), anterior–posterior
(Fy), and the vertical (Fz) forces were retained for further
analysis. The variables identified from these forces and
statistically considered are summarized in Table I and
graphically depicted in Fig 2.
Times from heel touch-down to the minimums andmax-
imums of the medial–lateral (Fx) and anterior–posterior (Fy)
curveswere calculated. Average curveswere also developed to
illustrate the average differences between groups. These
average curves were calculated as follows:
● A cubic spline algorithm was used to normalize the
data from each trial to 100 points for the stance
period.25
● The curves for each trial were averaged point-by-point
to generate an average curve for each subject for each
condition.
● These resulting curves are plotted in Fig 3 to assist in
the explanations of our results.
● The normalization procedure occurred after maxi-
mums and minimums and the other variables were
determined to ensure that normalization did not dis-
Table I. List of dependent variables examined and their d
Variable
Vertical force (Fz)
Fz1 First maximum for the Fz vertical
Fz2 Second maximum for the Fz verti
Fzmin Local minimum between maximu
Fz1  Fzmin Difference between F1 and Fmin
Fz2  Fzmin Difference between F2 and Fmin
Anterior–posterior force (Fy)
FyB Minimum of the Fy anterior–post
FyP Maximum of the Fy anterior–post
Braking impulse Area under the Fy anterior–poster
Propulsion impulse Area under the Fy anterior–poster
Medial–lateral force (Fx)
Fx max Maximum of the Fx medial-lateral
Fx min Minimum of the Fx medial-lateral
Impulse Fx total Area under the Fx medial-lateral f
Impulse Fx medial Area under the Fx medial-lateral f
Impulse Fx lateral Area under the Fx medial-lateral f
Time parameters
Stance Time of stance
Time to Fz1 Percentage of stance time to Fz1
Time to Fz2 Percentage of stance time to Fz2
Time to Fzmin Percentage of stance time to Fzmi
Time to FyB Percentage of stance time to FyB
Time to FyP Percentage of stance time to FyP
Time to Fxmax Percentage of stance time to Fxma
Time to Fxmin Percentage of stance time to Fxmitort these values.● Impulse (calculated as area under the curve; Fig 2)
parameters were normalized to stance time to allow
comparisons between populations.26
● Stance time was determined based on the Fz force
frequency and the number of points output from heel
touch-down to toe-off.
Statistical analysis. Statistical analysis was performed
using SigmaStat (Systat Software Inc, Point Richmond,
Calif). Subject and group means were calculated for all
dependent variables. Comparisons between claudication
subjects and control subjects were conducted using un-
paired t tests. In PAD subjects, parameters before onset of
claudication were compared with those after onset of clau-
dication using paired t testing. Correlations between PAD
severity and kinetic parameters were conducted using the
Pearson correlation. Results were expressed as mean values
 standard error unless otherwise specified.
RESULTS
The study recruited 14 PAD patients (age, 58  3.4
years; weight, 80.99  15.64 kg; height, 172.12  6.78
cm) with clinically diagnosed femoropopliteal occlusive
disease (ankle-brachial index [ABI], 0.56  0.03; range,
0.45 to 0.65). All patients had moderate claudication or
category 2 symptoms in the Rutherford classification,27 and
80% were hypertensive, 70% were smokers, 60% had dyslip-
idemia, and 30% were obese. All patients were treatment
naïve and were leading a sedentary lifestyle. From these 14
patients, we identified 20 PAD legs that were included for
evaluation in the present study. Five control subjects with
ption
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curve (medial force minimum)
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were also included. Two had dyslipidemia and one had
hypertension. BMI values were 28.5  0.98 for PAD
patients and 27.3  1.5 for control subjects. All control
subjects were leading a sedentary lifestyle. No significant
differences were noted between the two groups for age and
BMI.
Gait is impaired before and after onset of claudi-
cation. Claudicating patients demonstrate significant gait
alterations both before and after the onset of claudication
(Fig 3, Table II). Evaluation of the vertical force demon-
strates claudicating patients have a significantly higher mid-
stance minimum (Fzmin) and a significantly decreased dif-
ference between the second maximum and the midstance
minimum (Fz2  Fzmin) compared with controls (P 
.05). These results are reflected as a significant flattening of
the vertical force curve for the claudicating patients (Fig 3).
Fig 3. The mean curves for (A) the vertical forces, (B)
PRE, Peripheral arterial disease patients before onset of
after the onset of claudication.A more striking finding is the presence of these abnormal-ities in PAD limbs even before the onset of claudication
pain.
Anterior–posterior force evaluation revealed claudicat-
ing patients have significantly lowered peak propulsion
(FyP). PAD patients demonstrate decreased propulsion
force both before and after the onset of claudication (P 
.05; Fig 3).
Medial–lateral force curve evaluation shows claudicat-
ing patients have significantly decreased forces in the lateral
direction (early part of the stance), with increased forces in
the medial direction (later part of stance, Fig 3). The
difference in the medial forces becomes largest just before
toe-off. These findings are also seen in a significantly in-
creased area under the curve (ImpFx) for the claudicating
patients compared with controls (P  .05).
A significant increase in stance time, defined as time
from heel contact to toe-off, (P  .05) was noted for
or–posterior forces, and (C)medial–lateral forces. PAD
ication; PAD POST, peripheral arterial disease patientsanteri
claudclaudicating patients before and after the onset of claudica-
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curves demonstrates significant reduction in time to reach
Fz2, Fzmin, and FyP. These changes in claudicating patients
reflect a decrease in time spent in single-limb support, with
faster transition into double-limb support. Again, most of
these adaptations are displayed both before and after the
onset of claudication.
Gait parameters worsen after the onset of clau-
dication. After the onset of claudication, PAD patients
demonstrated significant worsening in multiple kinetic
parameters. Evaluation of the vertical force curve dem-
onstrated further flattening of the force curve, especially
in the second half of stance, reflected in a significantly
decreased difference between the second maximum and
the midstance minimum (Fz2  Fzmin). The anterior–
posterior curve evaluation showed that after onset of
claudication, PAD patients had a further significant drop
in their propulsion peak (FyP). In addition, evaluation of
the time parameters demonstrated claudication results in
prolongation of stance time, with corresponding short-
ening of the time to Fz2 and FyP. Because double-limb
support starts just before Fz2 and FyP, these findings
taken together indicate that the onset of claudication is
associated with prolongation of time spent in double-
limb support. Of note, the control subject’s gait was also
Table II. Comparison of different gait parameters in cont
after onset of claudication*
Control PAD P
Vertical (Fz)
Fz1 1.131  0.070 1.123  0
Fz2 1.058  0.051 1.081  0
Fzmin 0.752  0.059 0.870  0
Fz1  Fzmin 0.379  0.126 0.252  0
Fz2  Fzmin 0.307  0.096 0.211  0
Anterior-posterior (Fy)
FyB 0.168  0.023 0.172  0
FyP 0.205  0.024 0.170  0
Braking impulse 0.044  0.008 0.035  0
Propulsion impulse 0.045  0.005 0.032  0
Medial-lateral (Fx)
Fx max 0.057  0.024 0.038  0
Fx min 0.058  0.011 0.075  0
Impulse Fx total 0.029  0.004 0.040  0
Impulse Fx medial 0.024  0.004 0.038  0
Impulse Fx lateral 0.0042  0.002 0.0022  0
Time parameters
Stance 0.738  0.065 0.822  0
Time to Fz1 25.054  2.496 27.156  6
Time to Fz2 76.857  1.228 74.094  3
Time to Fzmin 50.199  3.039 46.472  5
Time to FyB 18.338  1.228 16.885  2
Time to FyP 84.476  0.651 84.118  1
Time to Fxmax 11.190  6.030 11.300  1
Time to Fxmin 38.082  21.880 39.853  1
PAD PRE, Patient before claudication onset; PAD POST, patient after clau
*For the description of each one of the gait parameters evaluated, please se
†Control vs PAD PRE.
‡Control vs PAD POST.
§PAD PRE vs PAD POST.evaluated after a 10-minute treadmill session (10% grade,0.67 m/s) to determine possible effects of fatigue
on biomechanical parameters. The assessment demon-
strated that controls have similar gate characteristics
before and after exercise (data not included).
DISCUSSION
Evaluation of claudicating patients by using advanced
biomechanical measures (ground reaction forces) provides
a new appreciation of the complexity of their ambulatory
impairment. Ground reaction forces can be resolved into
three components that are orthogonal to each other (ver-
tical, anterior–posterior, and medial–lateral).11 The vertical
ground reaction force curve is significantly flatter in claudi-
cating patients, both before and after onset of claudication,
compared with controls. The flatter configuration in clau-
dicating patients is the result of the absence of the normally
deep midstance “valley” (Fig 2 and Fig 3; reflected in a
higher Fzmin).
Because the vertical force curve mirrors the rise and fall
of the subject’s center of mass, this alteration indicates that
claudicating patients have significantly less vertical move-
ment of their center of mass compared with controls.
Decreased vertical fluctuation, especially in the second half
of stance, can be explained by an increase in time spent in
double-limb support and an inability to fully extend the
nd peripheral arterial disease patients both before and
P† PAD POST P‡ P§
NS 1.131  0.158 NS NS
NS 1.065  0.127 NS .05
.05 0.879  0.117 .05 NS
NS 0.251  0.188 NS NS
.05 0.186  0.126 .05 .05
NS 0.174  0.075 NS NS
NS 0.157  0.057 .05 .05
NS 0.037  0.013 NS NS
.05 0.030  0.009 .05 .05
.05 0.042  0.005 .05 NS
.05 0.073  0.005 .05 NS
.05 0.0377  0.003 .05 NS
.05 0.035  0.003 .05 NS
.05 0.0024  0.0003 .05 NS
.05 0.841  0.0160 .05 .05
NS 26.487  0.985 NS NS
.05 71.904  1.005 .05 .05
NS 45.293  0.956 .05 NS
NS 16.930  0.564 NS NS
NS 83.239  0.481 .05 .05
5 NS 8.771  0.903 NS NS
3 NS 44.704  19.163 NS .05
on onset; NS, statistically not significant.
e I. Data are presented as means  standard deviation.rols a
RE
.156
.128
.121
.181
.129
.072
.054
.011
.009
.017
.016
.004
.009
.001
.065
.480
.363
.792
.507
.125
0.64
7.83
dicati
e Tabllimb at single-limb support. Overall, the changes seen in
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 3 Scott-Pandorf et al 497the vertical forces indicate PAD patients adopt a walking
pattern that limits the natural up-and-down body motion
seen with normal ambulation. This may be the result of
dysfunction at themuscle level, decreased fine neural motor
control, or muscle pain inhibiting the ability to generate
force.
In the anterior–posterior direction, the second half of
stance is the indicator of impaired gait by the PAD patient.
This is the point of propulsion of the foot into the swing
phase. Even before the onset of claudication, PAD patients
demonstrate a tendency towards a smaller propulsion peak,
which becomes significantly smaller at the onset of claudi-
cation. Similarly, claudicating patients demonstrate de-
creased propulsion impulse both before and after the onset
of claudication. These findings indicate that claudicating
limbs have decreased ability to push off. Such a reduction in
forward impulse indicates a lack of strength and dysfunc-
tion in the propulsive muscles of the lower extremity or can
potentially be the result of purposeful action (ie, neural
control) to reduce the use of the painful limb.
Our force data for the medial–lateral direction, both in
the before-and-after onset of claudication conditions, dem-
onstrated PAD patients apply significantly higher forces in
the medial direction. This greater medial–lateral force fluc-
tuation by the claudicating subject is probably the result of
increased step width with reduction in single-limb support
time (increased time spent in double-limb support). A
larger step width creates increased forces in the medial–
lateral direction to maintain the wider stance.28 This pos-
sibility is further supported by our vertical curve data,
where the PAD patients maintain a lower center of gravity
throughout stance. As a result, during ambulation the
limbs need to be swung laterally to clear the ground
through to the next step. In adopting wider steps, greater
medial forces are then created.
In the case of reduction in time spent in single support,
PAD patients are pushing medially (generating the greater
medial forces found) to help shorten the swing phase of the
contralateral leg. As a result, the contralateral leg regains
contact with the ground more quickly and provides in-
creased double-limb support for the patient. Such adapta-
tions may be secondary to the PAD patient who seeks
security in his or her impaired gait. Adopting a wider step
and maintaining double-leg support for most of the gait
cycle, with less vertical fluctuations of the center of mass,
may contribute to a feeling of safety during locomotion.
Previous work has determined that elderly patients and
other pathologic populations such as those with Parkinson
disease or peripheral neuropathy walk slower.14,29 It has
been speculated that this change may be due to a need to
increase stability.30 Works from other laboratories as well as
our present data (longer stance time, increased double
support time) demonstrate that like the elderly, PAD pa-
tients adopt a slower walking pattern.4-7 Investigations of
elderly patients have reported stability and security gains
from walking with increased double support time and
slower velocity.30,31 This may be the underlying etiology
for the current findings in the PAD gait.Walking slower, however, has been found to increase
the metabolic cost of walking32 and may not offer more
stability.33 For a PAD patient, metabolic efficiency is vital
to functional mobility. A metabolically draining task will
decrease the time a patient can walk because the occluded
arteries cannot supply the needed energy to maintain the
task and pain will likely occur sooner. In addition, Gardner
and Montgomery8 described a higher incidence of self-
reported falling in PAD patients. If walking slower offers
stability for the patient, theoretically, they should not be
falling more often. Future investigations should further
evaluate the apparent clinical significance of these findings.
In the future, gait analysis may point to new rehabilitation
strategies that could correct the abnormal gait patterns,
allowing for greater exercise tolerance and improved bal-
ance in PAD patients.
When claudication pain is present, the vertical and
anterior–posterior force changes became more apparent.
The vertical force curve became even flatter, indicating
further reduction of the natural vertical fluctuation seen
with normal ambulation, and propulsion drops further,
suggesting that the function of muscles supporting propul-
sion worsens. Analysis of the time parameters shows pro-
longation of stance time with less time spent in single-limb
support (shortening of the time to Fz2 and FyP). These
findings indicate that the patient experiencing claudication
pain probably does not want to stand on the painful,
potentially weak and unsteady-feeling leg without alterna-
tive support.
As indicated in the results, a definite change occurs in
the gait of the PAD patient during the second half of the
stance phase. Further biomechanical analysis using kine-
matic data that evaluates the angles of the hip, knee, and
ankle joints may offer more insight into the specific propul-
sion compromise experienced by the ambulating claudicat-
ing patient. As noted in our results, no change in gait over
time was noted when the control subject’s gait was evalu-
ated after a 10-minute treadmill session. Therefore, it is
highly unlikely that the degradation of kinetic parameters
seen after the onset of claudication is the result of normal
exercise-related fatigue.
An unexpected finding in these series was that PAD
patients had evidence of significant ambulatory impair-
ments even when not experiencing any claudication pain.
In other words, the lower extremity neuromuscular system
of PAD patients appears to be dysfunctional at baseline,
before increased activity induces any appreciable ischemia
and pain. This finding is consistent with previous reports
that demonstrate a muscle metabolic myopathy34 and an
axonal polyneuropathy35 in the lower extremities of PAD
patients. Specifically, a number of reports have documented
a metabolic myopathy in PAD muscle that appears to be
secondary to defective mitochondrial bioenergetics. Mito-
chondria in PAD muscle have abnormal ultrastructure,36
damaged DNA,37 altered enzyme expression and activity,
and abnormally high intermediates of oxidative metabo-
lism.3 Most importantly, evaluation of the mitochondrial
bioenergetics of claudicating muscle demonstrates specific
JOURNAL OF VASCULAR SURGERY
September 2007498 Scott-Pandorf et aldefects in the complexes of electron transport chain, with
associated compromised mitochondrial respiration (oxida-
tive phosphorylation) and adenosine triphosphate produc-
tion38-41 that is very similar to those seen in mitochondrial
myopathies.34,38
In addition, accumulating evidence suggests that
chronic ischemia in PAD patients results in a consistent
pattern of electrodiagnostic abnormalities indicating ax-
onal nerve loss.35,42,43 Therefore, the impairments we have
identified at baseline may be reflecting a combination of
myopathy and neuropathy in the PAD limbs that gets worse
when exercise-induced ischemia produces pain and further
restriction of the lower extremity bioenergetics. Alterna-
tively, repeated episodes of exercise-induced ischemic pain
may lead to the establishment of a maladaptative gait in
claudicating patients and such adaptations may persist even
in the absence of pain.
CONCLUSION
Future research should build on the findings of this
investigation. Our current work describes the gait kinetic
alterations that occur in claudicating patients with femoro-
popliteal disease. Evaluation of patients with aortoiliac oc-
clusive disease or combined femoropopliteal and aortoiliac
occlusive disease should be the subject of similar future
investigation. In addition, more detailed biomechanical
analysis may include simultaneous evaluation of kinetics
(ground reaction forces) and kinematics (joint angles) in
the form of joint moments and powers. Such evaluation will
improve our understanding of the action of the muscles
across the joints of interest during gait, indicating specific
muscle group failure that can be correlated with the indi-
vidual patient’s level of occlusive disease and type of ambu-
latory handicap. Measuring the muscular action across a
joint in the PAD patient’s current gait style, then rehabili-
tating gait into becoming more like the healthy control,
and then evaluating again could offer important under-
standing of the adaptations by the PAD patient and, fur-
thermore, may determine the altered gait to be maladap-
tive.
The functional handicap of claudicating patients can-
not be fully understood without detailed studies of their
movement. The goal of this investigation was to character-
ize the gait of claudicating PAD patients by using detailed
kinetic biomechanical analysis. The results indicate clear
abnormalities in the gait of claudicating patients. These
abnormalities are present both before and after the onset of
claudication, with several of them becoming worse after
claudication onset. Our data indicate biomechanical analy-
sis can objectively quantify the ambulatory handicap of
PAD patients. Such analysis may facilitate the identification
of optimal rehabilitative regimens that could correct the
abnormal gait patterns, allowing for greater exercise toler-
ance. In addition, biomechanical evaluation may provide a
firm foundation for optimal clinical decision-making and,
more importantly, assist in an objective measurement of
functional outcomes after medical and surgical therapy.AUTHOR CONTRIBUTIONS
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